Αλισκιρένη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Αλισκιρένη" in Greek language version.

refsWebsite

Global rank Greek rank

7doi.org

2^nd place

3^rd place

6worldcat.org

5^th place

8^th place

4nih.gov

4^th place

2web.archive.org

1^st place

2fda.gov

447^th place

368^th place

1prescrire.org

low place

1thestar.com

336^th place

2,597^th place

1nejm.org

2,374^th place

2,218^th place

1ahajournals.org

3,608^th place

1,928^th place

1thelancet.com

2,393^rd place

1,822^nd place

1drugs.com

399^th place

130^th place

1pharmaxchange.info

low place

5,771^st place

ahajournals.org

Gradman, Alan H.; Schmieder, Roland E.; Lins, Robert L.; Nussberger, Juerg; Chiang, Yanntong; Bedigian, Martin P. (2005-03). «Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients» (στα αγγλικά). Circulation 111 (8): 1012–1018. doi:10.1161/01.CIR.0000156466.02908.ED. ISSN 0009-7322. https://www.ahajournals.org/doi/10.1161/01.CIR.0000156466.02908.ED.

doi.org

dx.doi.org

Gradman, Alan H.; Schmieder, Roland E.; Lins, Robert L.; Nussberger, Juerg; Chiang, Yanntong; Bedigian, Martin P. (2005-03). «Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients» (στα αγγλικά). Circulation 111 (8): 1012–1018. doi:10.1161/01.CIR.0000156466.02908.ED. ISSN 0009-7322. https://www.ahajournals.org/doi/10.1161/01.CIR.0000156466.02908.ED.
Staessen, Jan A.; Li, Yan; Richart, Tom (2006-10-21). «Oral renin inhibitors» (στα English). The Lancet 368 (9545): 1449–1456. doi:10.1016/S0140-6736(06)69442-7. ISSN 0140-6736. PMID 17055947. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(06)69442-7/abstract.
«Fusafungine-containing medicines should be withdrawn, says European Medicines Agency». The Pharmaceutical Journal. 2016. doi:10.1211/pj.2016.20200711. ISSN 2053-6186. http://dx.doi.org/10.1211/pj.2016.20200711.
Rahuel, J; Rasetti, V; Maibaum, J; Rüeger, H; Göschke, R; Cohen, N-C; Stutz, S; Cumin, F και άλλοι. (2000-07). «Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin». Chemistry & Biology 7 (7): 493–504. doi:10.1016/s1074-5521(00)00134-4. ISSN 1074-5521. http://dx.doi.org/10.1016/s1074-5521(00)00134-4.
Baldwin, Claudine M.; Plosker, Greg L. (2009-05-01). «Aliskiren/Hydrochlorothiazide Combination» (στα αγγλικά). Drugs 69 (7): 833–841. doi:10.2165/00003495-200969070-00004. ISSN 1179-1950. https://doi.org/10.2165/00003495-200969070-00004.
Ingelfinger, Julie R. (2008-06-05). «Aliskiren and dual therapy in type 2 diabetes mellitus». The New England Journal of Medicine 358 (23): 2503–2505. doi:10.1056/NEJMe0803375. ISSN 1533-4406. PMID 18525047. https://pubmed.ncbi.nlm.nih.gov/18525047/.

doi.org

Baldwin, Claudine M.; Plosker, Greg L. (2009-05-01). «Aliskiren/Hydrochlorothiazide Combination» (στα αγγλικά). Drugs 69 (7): 833–841. doi:10.2165/00003495-200969070-00004. ISSN 1179-1950. https://doi.org/10.2165/00003495-200969070-00004.

drugs.com

«Tekturna: Package Insert / Prescribing Information». Drugs.com (στα Αγγλικά). Ανακτήθηκε στις 9 Ιανουαρίου 2023.

fda.gov

Research, Center for Drug Evaluation and (2021-06-29). «FDA Drug Safety Communication: New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna)» (στα αγγλικά). FDA. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-new-warning-and-contraindication-blood-pressure-medicines-containing.
Research, Center for Drug Evaluation and (2018-11-03). «Aliskiren Information» (στα αγγλικά). FDA. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/aliskiren-information.

nejm.org

https://www.nejm.org/doi/10.1056/NEJMoa1208799. Missing or empty |title= (βοήθεια)

nih.gov

ncbi.nlm.nih.gov

Staessen, Jan A.; Li, Yan; Richart, Tom (2006-10-21). «Oral renin inhibitors» (στα English). The Lancet 368 (9545): 1449–1456. doi:10.1016/S0140-6736(06)69442-7. ISSN 0140-6736. PMID 17055947. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(06)69442-7/abstract.
Ingelfinger, Julie R. (2008-06-05). «Aliskiren and dual therapy in type 2 diabetes mellitus». The New England Journal of Medicine 358 (23): 2503–2505. doi:10.1056/NEJMe0803375. ISSN 1533-4406. PMID 18525047. https://pubmed.ncbi.nlm.nih.gov/18525047/.

pubchem.ncbi.nlm.nih.gov

PubChem. «Aliskiren». pubchem.ncbi.nlm.nih.gov (στα Αγγλικά). Ανακτήθηκε στις 9 Ιανουαρίου 2023.

pubmed.ncbi.nlm.nih.gov

Ingelfinger, Julie R. (2008-06-05). «Aliskiren and dual therapy in type 2 diabetes mellitus». The New England Journal of Medicine 358 (23): 2503–2505. doi:10.1056/NEJMe0803375. ISSN 1533-4406. PMID 18525047. https://pubmed.ncbi.nlm.nih.gov/18525047/.

pharmaxchange.info

«PharmaXChange.info - Direct Renin Inhibitors As Antihypertensive Drugs». web.archive.org. 7 Δεκεμβρίου 2010. Αρχειοθετήθηκε από το πρωτότυπο στις 7 Δεκεμβρίου 2010. Ανακτήθηκε στις 9 Ιανουαρίου 2023.

prescrire.org

english.prescrire.org

«In the June issue of Prescrire International -Towards better patient care: drugs to avoid in 2014». english.prescrire.org. Ανακτήθηκε στις 6 Ιανουαρίου 2023.

thelancet.com

Staessen, Jan A.; Li, Yan; Richart, Tom (2006-10-21). «Oral renin inhibitors» (στα English). The Lancet 368 (9545): 1449–1456. doi:10.1016/S0140-6736(06)69442-7. ISSN 0140-6736. PMID 17055947. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(06)69442-7/abstract.

thestar.com

«Blood-pressure drug reviewed amid dangerous side effects». thestar.com (στα Αγγλικά). 22 Δεκεμβρίου 2011. Ανακτήθηκε στις 6 Ιανουαρίου 2023.

web.archive.org

«First Hypertension Drug to Inhibit Kidney Enzyme Approved». web.archive.org. 22 Μαρτίου 2007. Αρχειοθετήθηκε από το πρωτότυπο στις 22 Μαρτίου 2007. Ανακτήθηκε στις 6 Ιανουαρίου 2023. CS1 maint: Unfit url (link)
«PharmaXChange.info - Direct Renin Inhibitors As Antihypertensive Drugs». web.archive.org. 7 Δεκεμβρίου 2010. Αρχειοθετήθηκε από το πρωτότυπο στις 7 Δεκεμβρίου 2010. Ανακτήθηκε στις 9 Ιανουαρίου 2023.

worldcat.org

Gradman, Alan H.; Schmieder, Roland E.; Lins, Robert L.; Nussberger, Juerg; Chiang, Yanntong; Bedigian, Martin P. (2005-03). «Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients» (στα αγγλικά). Circulation 111 (8): 1012–1018. doi:10.1161/01.CIR.0000156466.02908.ED. ISSN 0009-7322. https://www.ahajournals.org/doi/10.1161/01.CIR.0000156466.02908.ED.
Staessen, Jan A.; Li, Yan; Richart, Tom (2006-10-21). «Oral renin inhibitors» (στα English). The Lancet 368 (9545): 1449–1456. doi:10.1016/S0140-6736(06)69442-7. ISSN 0140-6736. PMID 17055947. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(06)69442-7/abstract.
«Fusafungine-containing medicines should be withdrawn, says European Medicines Agency». The Pharmaceutical Journal. 2016. doi:10.1211/pj.2016.20200711. ISSN 2053-6186. http://dx.doi.org/10.1211/pj.2016.20200711.
Rahuel, J; Rasetti, V; Maibaum, J; Rüeger, H; Göschke, R; Cohen, N-C; Stutz, S; Cumin, F και άλλοι. (2000-07). «Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin». Chemistry & Biology 7 (7): 493–504. doi:10.1016/s1074-5521(00)00134-4. ISSN 1074-5521. http://dx.doi.org/10.1016/s1074-5521(00)00134-4.
Baldwin, Claudine M.; Plosker, Greg L. (2009-05-01). «Aliskiren/Hydrochlorothiazide Combination» (στα αγγλικά). Drugs 69 (7): 833–841. doi:10.2165/00003495-200969070-00004. ISSN 1179-1950. https://doi.org/10.2165/00003495-200969070-00004.
Ingelfinger, Julie R. (2008-06-05). «Aliskiren and dual therapy in type 2 diabetes mellitus». The New England Journal of Medicine 358 (23): 2503–2505. doi:10.1056/NEJMe0803375. ISSN 1533-4406. PMID 18525047. https://pubmed.ncbi.nlm.nih.gov/18525047/.